Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis

NCT07592403 · ctgov recruiting

Enrollment: 60
Start: 2026-05-16
Completion: 2027-01-30
Last updated: 2026-05-19
Has results: False
Countries: Egypt

Conditions

EndometriosisPulsed Electromagnetic TherapyTrans Perineal Ultrasound

Tagged with

endometriosis

Interventions

Pulsed Electromagnetic Field Therapy DEVICE
PEMF will be applied using a low-frequency pulsed electromagnetic stimulation device with sinusoidal waveform output targeting the lower abdominal and pelvic regions. Treatment sessions will be administered three times weekly for 8 consecutive weeks, with each session lasting approximately 20 minutes. Treatment parameters will include pulsed frequency ranging from 10 Hz, magnetic field intensity ranging from 2 mT, and pulse duration ranging from 250 microseconds. Standard medical care include stable hormonal therapy and prescribed analgesic medications without modification during the study period.
Sham pulsed electromagnetic field therapy DEVICE
Participants in this group will receive sham pulsed electromagnetic field therapy sessions in addition to stable standard medical care. The sham device will appear identical to the active device in shape, sound, and operating indicators without delivering therapeutic electromagnetic output. Session duration, participant positioning, and treatment frequency will match those of the experimental group.

Eligibility criteria

Inclusion Criteria: 1. Women aged 18 to 45 years 2. Clinically, radiologically, or laparoscopically diagnosed endometriosis 3. Chronic pelvic pain persisting for at least 6 months 4. Stable pharmacological or hormonal treatment for at least 3 months before enrollment 5. Ability to understand study procedures and provide written informed consent Exclusion Criteria: 1. Pregnancy or planned pregnancy during the study period 2. History of gynecological or pelvic malignancy 3. Active pelvic inflammatory disease or acute pelvic infection 4. Implanted electronic medical devices such as pacemakers or neurostimulators 5. Previous pelvic surgery within the past 6 months 6. Participation in another clinical trial during the previous 3 months 7. Neurological, rheumatological, or severe musculoskeletal disorders affecting assessment procedures 8. Contraindications to electromagnetic therapy

License: public-domain-us · commercial use OK · attribution required
Courtesy of ClinicalTrials.gov / U.S. National Library of Medicine